Carta a la editora
Medwave 2014 Oct;14(9):e6025 doi: 10.5867/medwave.2014.09.6025
Cicatrices visibles de vacunación
Visible vaccination scars
Juan Enrique Berner, Pedro Vidal
Referencias | Descargar PDF |
Para Descargar PDF debe Abrir sesión.
Imprimir | A(+) A(-) | Lectura fácil

Since Edward Jenner introduced Vaccinology in the late eighteenth century, vaccines have saved millions of lives around the world. As an example, smallpox—responsible for 8 to 20% of mortality in Europe—was eradicated decades ago, and polio is not far from the same fate. Moreover, there are vaccines available for prevention of 24 other communicable infectious diseases. This is a key factor in the increased life expectancy witnessed in the last hundred years [2].

Chile has led the region in immunization programs. The smallpox vaccine was introduced in 1887, and by 1950, the disease had disappeared in the country. In 1949, tuberculosis (Bacillus Calmette-Guerin) BCG vaccination was introduced, giving way to a free universal vaccination program that covered each and every Chilean child with BCG, MMR (measles, mumps, and rubella), and DPT (diphtheria, pertussis, and tetanus) vaccines.

Thanks to this program, Chile was the third country able to eradicate polio in 1976, and to achieve the goal of controlling measles and rubella before the end of the century [3].

It is beyond discussion that immunization programs have been of paramount importance in Chile´s outstanding child mortality rates. Chileans carry on their upper arms multiple vaccination scars. However, some scars, can become hypertrophic or even become keloids [4]. There are also reports of shoulder joint damage following vaccination [5].

The choice of the upper arm or shoulder area as a vaccination site was probably due to ease of access. However, concern about scarring in exposed body areas may be a cause for a change of vaccination site and the choice of an easier-to-conceal place. The buttocks seem a more reasonable site.

We believe that a change in the traditional site of immunization would benefit a large number of patients who one day may appreciate not having visible vaccination scars.

Notes

Conflicts of interest
The authors have completed the ICMJE uniform disclosure form, translated into Spanish by Medwave (available on request from the corresponding author), and declare not having conflicts of interest with the subject of the letter.

Licencia Creative Commons Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

 

Authors: Juan Enrique Berner[1], Pedro Vidal[1,2]

Filiación:
[1] Hospital Clínico Fuerza Aérea de Chile "Gral. Dr. Raúl Yazigi J.", Santiago, Chile
[2] Departamento de Cirugía Plástica, Escuela de Medicina, Pontificia Universidad Católica de Chile

E-mail: jeberner@gmail.com

Correspondencia a:
[1] Lo Fontecilla 101 oficina 412
Las Condes
Santiago Chile

Citación: Berner JE, Vidal P. Visible vaccination scars. Medwave 2014 Oct;14(9):e6025 doi: 10.5867/medwave.2014.09.6025

Fecha de publicación: 17/10/2014

Ficha PubMed

Comentarios (2)

Nos complace que usted tenga interés en comentar uno de nuestros artículos. Su comentario será publicado inmediatamente. No obstante, Medwave se reserva el derecho a eliminarlo posteriormente si la dirección editorial considera que su comentario es: ofensivo en algún sentido, irrelevante, trivial, contiene errores de lenguaje, contiene arengas políticas, obedece a fines comerciales, contiene datos de alguna persona en particular, o sugiere cambios en el manejo de pacientes que no hayan sido publicados previamente en alguna revista con revisión por pares.

Nombre/name: Jaime Rodrigo Cerda
Fecha/date: 2014-10-28 16:20:16
Comentario/comment:
Respetuosamente, difiero del planteamiento de los Drs. Berner y Vidal. Existen razones técnicas para no administrar vacunas en los glúteos. Al respecto, Zuckerman aporta una breve explicación sobre cuál debiese ser el sitio de administración (BMJ. Nov 18, 2000; 321(7271): 1237–1238).

"Traditionally the buttocks were thought to be an appropriate site for vaccination, but the layers of fat do not contain the appropriate cells that are necessary to initiate the immune response (phagocytic or antigen-presenting cells). The antigen may also take longer to reach the circulation after being deposited in fat, leading to a delay in processing by macrophages and eventually presentation to the T and B cells that are involved in the immune response. In addition, antigens may be denatured by enzymes if they remain in fat for hours or days. The importance of these factors is supported by the findings that thicker skinfolds are associated with a lowered antibody response to vaccines".

Les saluda atentamente,

Dr. Jaime Cerda
Profesor Asistente, Facultad de Medicina PUC
Comité Consultivo de Inmunizaciones
Sociedad Chilena de Infectología.

Nombre/name: Vivienne Bachelet
Fecha/date: 2014-10-29 07:48:01
Comentario/comment:
Cuando yo debí ser vacunada, vivía en Suecia (mi padre era diplomático de carrera en aquella época). Las vacunas me las colocaron en la parte interna del brazo, por lo que no quedaron a la vista. Fue hace muchos años atrás, y siempre me llamó la atención, siendo una especie de orgullo para mí tener la marca en otro sitio.


Para comentar debe iniciar sesión

Medwave publica las vistas HTML y descargas PDF por artículo, junto con otras métricas de redes sociales.

Se puede producir un retraso de 48 horas en la actualización de las estadísticas.

  1. André FE. Vaccinology: past achievements, present roadblocks and future promises. Vaccine. 2003 Jan 30;21(7-8):593-5. | CrossRef | PubMed |
  2. Artenstein AW, Poland GA. Vaccine history: the past as prelude to the future. Vaccine. 2012 Aug 3;30(36):5299-301. | CrossRef | PubMed |
  3. Valenzuela B. MT. Desarrollo y futuro del Programa Ampliado de Inmunizaciones en Chile. Rev Chil Infectol. 2001;18(1):31–6. | CrossRef |
  4. Coop CA, Schaefer SM, England RW. Extensive keloid formation and progression after each vaccination. Hum Vaccin. 2007 Jul-Aug;3(4):127-9. | PubMed |
  5. Bodor M, Montalvo E. Vaccination-related shoulder dysfunction. Vaccine. 2007 Jan 8;25(4):585-7. | CrossRef | PubMed |
André FE. Vaccinology: past achievements, present roadblocks and future promises. Vaccine. 2003 Jan 30;21(7-8):593-5. | CrossRef | PubMed |

Artenstein AW, Poland GA. Vaccine history: the past as prelude to the future. Vaccine. 2012 Aug 3;30(36):5299-301. | CrossRef | PubMed |

Valenzuela B. MT. Desarrollo y futuro del Programa Ampliado de Inmunizaciones en Chile. Rev Chil Infectol. 2001;18(1):31–6. | CrossRef |

Coop CA, Schaefer SM, England RW. Extensive keloid formation and progression after each vaccination. Hum Vaccin. 2007 Jul-Aug;3(4):127-9. | PubMed |

Bodor M, Montalvo E. Vaccination-related shoulder dysfunction. Vaccine. 2007 Jan 8;25(4):585-7. | CrossRef | PubMed |